Iovance Biotherapeutics
Price & Volume
Stats
See moreOpen | $2.34 |
Previous Close | $2.35 |
Day Range | $2.34-$2.40 |
52W Range | $1.64-$6.50 |
Market Cap | $952.7M |
Shares Short | 119M |
Financials
See moreRevenue (12 Mos) | $250.4M |
Revenue Growth (YoY) | 15.2% |
Gross Profit (12 Mos) | $51.8M |
Diluted EPS | -$1.19 |
News
See moreYahoo Finance • 14 days ago
Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review
Yahoo Finance • 16 days ago
2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street
Yahoo Finance • 26 days ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Iovance Biotherapeutics reports mixed Q3 results; reaffirms FY25 outlook
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 838 |
